Neulasta Package Insert

HIGHLIGHTS OF PRESCRIBING INFORMATION ...
2 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Ovarian Cancer GEMZAR®in combination with carboplatin is indicated for the treatment of patients with advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy. ... Retrieve Document

KLONOPIN TABLETS (clonazepam) Rx Only
Pharmacokinetics: Clonazepam is rapidly and completely absorbed after oral administration. The absolute bioavailability of clonazepam is about 90%. Maximum plasma concentrations of clonazepam are reached within 1 to 4 hours after oral administration. Clonazepam is approximately 85% bound to plasma proteins. ... Fetch This Document

Reference ID: 3846752 - Food And Drug Administration
Neulasta is administered subcutaneously via a single prefilled syringe for manual use or for use with the On-body Injector for Neulasta which is co-packaged with a single prefilled syringe. Use of the On-body Injector for Neulasta ... View Doc

MRxM Neulasta 08 15 ICD10 - Magellan Provider
Neulasta® Prior Authorization Criteria ©2016 Health New England, Inc. Page 2 of 9 This HNE clinical criteria is only a screening tool. ... Read Here

HIGHLIGHTS OF PRESCRIBING INFORMATION
HIGHLIGHTS OF PRESCRIBING INFORMATION . 1. 1 2 3 4 5 6 7 8 9 10 . These highlights do not include all the information needed to use ADVATE safely and effectively. ... Document Retrieval

Colony Stimulating Factors: Neulasta® (pegfilgrastim)
1. Neulasta [package insert]. Thousand Oaks, CA; Amgen Inc; December 2017. Accessed January 2018. 2. Referenced with permission from the NCCN Drugs & Biologics Compendium (NCCN Compendium®) pegfilgrastim. National Comprehensive Cancer Network, 2018. The NCCN Compendium® is a derivative work of the NCCN Guidelines®. NATIONAL ... Fetch Content

Package Leaflet: Information For The User Neulasta 6 Mg ...
Package leaflet: Information for the user Neulasta 6 mg solution for injection pegfilgrastim Read all of this leaflet carefully before you start using this medicine because it contains important information for you. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. ... Access Full Source

Label - Pegfilgrastim (Neulasta), Amgen Incorporated
Patient Package Insert Neulasta (pegfilgrastim) Page 2 of 9 Amgen Thousand Oaks AMGEN Occasionally a reaction may develop at the injection site. If there is a lump, swelling, or ... Retrieve Doc

HIGHLIGHTS OF PRESCRIBING INFORMATION NEULASTA Safely And ...
Neulasta.If the prefilled syringe co-packaged in Neulasta Onpro kitis used for manual subcutaneous injection, the patient will receive an overdose. If the single-doseprefilled syringe for manual use is usedwith the OBIfor Neulasta, the patient may receive less than the recommended dose. ... Read Document

D (S) Neulasta (pegfilgrastim)
*Neulasta is the only G-CSF product used in the published clinical trials for these regimens. The requesting provider should provide journal citations supporting this request for regimens other than those listed. ... Get Doc

HIGHLIGHTS OF PRESCRIBING INFORMATION Acute Respiratory ...
1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Neulasta safely and effectively. See full prescribing informationfor Neulasta. ... Access Document

HIGHLIGHTS OF PRESCRIBING INFORMATION These Highlights Do Not ...
FULPHILA (pegfilgrastim-jmdb) is biosimilar* to NEULASTA® (pegfilgrastim). (1) -----INDICATIONS AND USAGE-----Fulphila is a leukocyte growth factor indicated to • Decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving ... Retrieve Content

Neulasta CC - Arise Health Plan
Pegfilgrastim injection (Neulasta®) Date reviewed: 12/9/2009. Description. Like filgrastim (Neupogen), pegfilgrastim is a human granulocyte colony stimulating factor (G-CSF) which acts on hematopoietic cells and has various functions such as stimulating the production of neutrophils within the bone marrow. ... Access Full Source

NEULASTA (pegfilgrastim), FULPHILA (pegfilgrastim-jmdb ...
Neulasta (pegfilgrastim) and Fulphila (pegfilgrastim-jmdb) are granulocyte colony-stimulating factors (G-CSF) that act on hematopoietic cells by binding to specific cell surface receptors, thereby stimulating proliferation, differentiation, commitment, and end cell functional activation. ... Retrieve Full Source

HIGHLIGHTS OF PRESCRIBING INFORMATION ... - GRANIX
1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GRANIX safely and effectively. See full prescribing information for GRANIX. ... Access Content

HIGHLIGHTS OF PRESCRIBING INFORMATION With A Fluoropyrimidine ...
3 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Melanoma KEYTRUDA®(pembrolizumab) is indicated for the treatment of patients with unresectable or metastatic melanoma [see Clinical Studies (14.1)]. 1.2 Non-Small Cell Lung Cancer ... Doc Retrieval

Neulasta (pegfilgrastim) OnproTM Kit Healthcare Provider ...
A Remove Neulasta Onpro kit from refrigerator. Check to make sure it contains: One Neulasta prefilled syringe Instructions for use: One On-body Injector for Neulasta – for healthcare provider Neulasta package insert – for patient ... View Full Source